WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
1. (WO2018101269) ORAL AGENT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/101269    International Application No.:    PCT/JP2017/042649
Publication Date: 07.06.2018 International Filing Date: 28.11.2017
A61K 31/045 (2006.01), A61K 9/48 (2006.01), A61K 31/122 (2006.01), A61K 31/202 (2006.01), A61K 47/14 (2006.01), A61K 47/34 (2017.01), A61P 3/00 (2006.01)
Applicants: LION CORPORATION [JP/JP]; 3-7, Honjo 1-chome, Sumida-ku, Tokyo 1308644 (JP)
Inventors: KANESHIMA, Daisuke; (JP).
SUGAFUJI, Toshihiro; (JP).
MATSUNO, Ayumi; (JP).
YAMAGA, Hiroaki; (JP).
ORIHARA, Yoichi; (JP)
Agent: SAKAI INTERNATIONAL PATENT OFFICE; Toranomon Mitsui Building, 8-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo 1000013 (JP)
Priority Data:
2016-233604 30.11.2016 JP
(JA) 内服剤
Abstract: front page image
(EN)The purpose of the present invention is to provide: an oral agent including two or more oily components, wherein the oral agent is capable of exhibiting a good balance between dispersibility and stability; and a method for producing a soft capsule agent. The present invention is: an oral agent including component (A): an n-3 fatty acid such as docosahexaenoic acid, component (B): a crystalline oily component such as lutein, capsanthin, zeaxanthin, β-cryptoxanthin, and astaxanthin, and component (C): a glycerin fatty acid ester or polyglycerin fatty acid ester having an HLB of 5 or lower; and a method for producing a soft capsule agent.
(FR)L’invention a pour objet de fournir une préparation à usage interne contenant deux composants huileux ou plus, et permettant de développer un équilibre satisfaisant entre propriétés de dispersion et stabilité, et de fournir un procédé de fabrication d’une préparation à capsule mole. Plus précisément, l’invention concerne une préparation à usage interne et une préparation à capsule mole, laquelle préparation à usage interne contient : en tant que composant (A), un acide gras n-3 tel qu’un acide docosahexaénoïque ; en tant que composant (B), un composant huileux cristallin tel qu’une lutéine, une capsanthine, une zéaxanthine, une β-cryptoxanthine, une astaxanthine, ou similaire ; et en tant que composant (C), un ester d’acides gras de glycérine ou de polyglycérine de balance-hydrophile-lipophile inférieure ou égale à 5.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)